Akouos, Inc. (AKUS) Stock Analysis
DELISTED 2022
What happened to Akouos, Inc. (AKUS) stock?
Akouos, Inc. (AKUS) no longer trades on public markets. It was delisted in November 2022. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2022
- Last recorded price (historical):
- $13.29 (last quote on record before the November 2022 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Akouos, Inc. (AKUS). Akouos, Inc. is a precision genetic medicine company focused on developing gene therapies for hearing loss. Their platform utilizes adeno-associated viral vectors to target genes responsible for various forms of hearing impairment.
Last analyzed: May 10, 2026Akouos, Inc. (AKUS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy AKUS shares?
No. AKUS stopped trading on public markets in November 2022, so the shares are not available through a broker. Anything you see quoted for AKUS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AKUS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Akouos, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.